News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter
Voices
FDA Approvals
New Paper Alert
Community
Career Updates
Drugs
Dialogues
Stories

Celebrities
Cancer Types
Radiotherapy
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Immune Oncology
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
Industry
Public Health
Techology
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
Oncothon 2025
Yvonne Award 2025

Sep / 2025

September 2025
M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

« Aug

OncoDaily IO OncoDaily GI Hemostasis Today

Voices
FDA Approvals
New Paper Alert
Community
Career Updates
Drugs
Dialogues
Stories

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter

France Grants Reimbursed Compassionate Access for BOT/BAL in Refractory MSS Colorectal Cancer

$France Grants Reimbursed Compassionate Access for BOT/BAL in Refractory MSS Colorectal Cancer 1$

SIOG and OncoDaily Announce Strategic Partnership to Advance Global Geriatric Oncology

SIOG

Winners Cup 2025: More Than Football, A Celebration of Life

Winners Cup

Global Leaders in Cancer Research Join OncoDaily’s Editorial Board

Cancer research

Top Colorectal Cancer Trials to Watch at ESMO 2025

Top Colorectal trials

35 posts not to miss from WCLC24 Day 4

WCLC24

NIH Launches a New Initiative to Create a 21st Century Biosafety Framework

NIH Launches a New Initiative to Create a 21st Century Biosafety Framework

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology

Jan Cools

Apr 2, 2025 12:29 pm

Blog Posts

4th Translational Research Conference on Acute Lymphoblastic Leukaemia – ESH

Translational Research Conference

Jul 14, 2024 7:13 am

Blog Posts

The main scientific topics of ESHALL2025

ESH

Jul 4, 2024 8:53 am

Blog Posts

Jan Cools: 2023 journal impact factor of HemaSphere Journal is 12.1

Jan Cools

Mar 9, 2024 2:13 pm

Insight

Jan Cools: A single-cell expression atlas of 119,000 AML cells and AML stem cells in paired diagnostic-relapse samples

Jan Cools: A single-cell expression atlas of 119,000 AML cells and AML stem cells in paired diagnostic-relapse samples

Sep 9, 2023 8:36 pm

Blog Posts

Jan Cools: I am very excited to announce an update on the 2022 journal impact factor of Hema Sphere Journal – the new projected impact factor is 9.1 and will be released by Clarivate in the October JCR update

Jan Cools

Headlines

Neoadjuvant Therapy in RCC: Dr. Axel Bex Reviews Evidence and Future Directions at VIRO 2025

Dr. Brad McGregor on Prognostic Models and Adjuvant Therapy in RCC at VIRO 2025

Gang Zhu about Advancing Urologic Oncology with Holographic Imaging and Robotic Surgery at VIRO 2025

Day 2 of VIRO 2025 Begins

Global Voices in Renal Oncology (VIRO) 2025: A Day of Insights, Innovation, and Collaboration

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: [email protected]

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

OncoDaily

Oncology

cancer

fight against cancer

Global fight against cancer

cancer care

Breast Cancer

ASCO

Lung cancer

Cancer research

MD Anderson Cancer Center

cancer awareness

NSCLC

ESMO

immunotherapy

cancer treatment

Research

ASCO24

Headlines

colorectal cancer

Childhood Cancer

prostate cancer

AACR

clinical trials

FDA

Dana-Farber Cancer Institute

UICC

American Cancer Society

European Cancer Organisation

NCI

National Cancer Institute

healthcare

SIOP

ASCO25

chemotherapy

Vivek Subbiah

AI

American Society of Clinical Oncology

Paolo Tarantino

IASLC

WHO

multiple myeloma

Robert Orlowski

Memorial Sloan Kettering Cancer Center

Zainab Shinkafi-Bagudu

radiation oncology

Myeloma Paper of the Day

cervical cancer

patient care

Myeloma

European School of Oncology

Sitemap

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options Manage services Manage {vendor_count} vendors Read more about these purposes

View preferences

{title} {title} {title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options Manage services Manage {vendor_count} vendors Read more about these purposes

View preferences

{title} {title} {title}